ClinicalTrials.Veeva

Menu

Correlating the Measure of Retinal Vascular Density Through Angio-OCT with Calcium Score (ANOSCA)

C

Centre Hospitalier Universitaire de Besancon

Status

Completed

Conditions

Cardiovascular Abnormalities
Retinal Vascular
Vascular Diseases

Treatments

Other: Ophthalmologic consultation

Study type

Interventional

Funder types

Other

Identifiers

NCT05624255
2022/701

Details and patient eligibility

About

Recent case-control studies have proven that the retinal vascularization mirrors the cardiac vascularization: more the coronary network is altered, more the density of retinal vessels is reduced. No studies have yet been realised in primary prevention. This study aims to demonstrate a link between the density of the retinal vascularization and the calcium score, which is currently the gold standard for the classification of cardiovascular risk in primary prevention. Thus, a simple image of the retinal vascularization could predict the cardiovascular risk of a patient. OCT angiography would become a major aid in the classification of cardiovascular risk in asymptomatic patients.

Enrollment

101 patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients eligible for a calcium score as part of their standard treatment and volunteers for an ophthalmologic consultation

Exclusion criteria

  • Pregnant women

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

101 participants in 1 patient group

ophthalmology consultation
Experimental group
Description:
Patients eligible to calcium score will be offered an ophthalmologic consultation including Angio-Optical Coherence Tomography \[OCT\]
Treatment:
Other: Ophthalmologic consultation

Trial contacts and locations

1

Loading...

Central trial contact

Anne-Sophie GAUTHIER, MD PhD; Valentin WETZEL, Int

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems